For example, the serum GPC1 levels were higher in hepatocellular carcinoma (P < 0.001), cholangiocarcinoma (P < 0.001), gastric carcinoma (P = 0.019), and prostate cancer (P = 0.01) than in HC. This evidence concerns the gene GPC1 and prostate carcinoma.